Olin
Manufactures chlorine-chain chemicals, epoxies and Winchester ammunition.
Something off on this page? Send us feedback.
Profile
Manufactures and sells chlorine-chain chemicals, vinyls and epoxies alongside Winchester ammunition. The vertically integrated chemical operation and U.S. ammunition franchise were expanded by the Dow chlorine-business transaction.
Produces chlorine and caustic soda, vinyls, chlorinated organics and epoxies, alongside Winchester ammunition. The chemical business also includes bleach and hydrochloric acid; Winchester produces sporting, law-enforcement, reloading, small-caliber military and industrial ammunition products. Winchester's range includes both sporting products and small-caliber military ammunition.
A vertically integrated global chemical operation sits alongside U.S. ammunition manufacturing. The addition of Dow's chlorine, vinyl, chlorinated-organics and epoxy businesses expanded the chemicals portfolio; the Mathieson merger and Winchester acquisition underpin its current shape. A proposed all-stock combination with Huntsman remains pending shareholder and regulatory approvals.
Company facts
Key statistics
Year to date −20.4% · Average volume (30d) 3.1M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Deutsche Bank | Reiterate | Hold | $26 | $20 | |
| Aug 4, 2026 | Goldman Sachs | Reiterate | Neutral | $24 | $20 | |
| Aug 4, 2026 | Wells Fargo | Downgrade | Overweight | Equal Weight | ||
| Aug 3, 2026 | Wells Fargo | Target | $37 | $20 | ||
| Aug 3, 2026 | RBC Capital | Reiterate | Sector Perform | $30 | $20 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026Q2 FY26 | $0.07 | $0.07 | 0.0% | $1.81B | $1.74B | −3.5% | −16.51% |
| May 7, 2026Q1 FY26 | −$0.67 | −$0.65 | +3.0% | $1.62B | $1.58B | −2.3% | +0.30% |
| Jan 29, 2026Q4 FY25 | −$0.64 | −$0.58 | +9.2% | $1.54B | $1.67B | +8.2% | −6.85% |
| Oct 27, 2025Q3 FY25 | $0.08 | $0.40 | +426.9% | $1.73B | $1.71B | −1.2% | −12.45% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.64B | $1.76B | $1.71B | $1.67B | $1.58B | $1.74B | |
| Gross profit | $148.7M | $138.1M | $183.4M | $31.3M | $75.8M | $170.2M | |
| Operating income | $43.7M | $35.3M | $400.0K | −$62.7M | −$69.2M | $46.5M | |
| Net income | $1.4M | −$1.3M | $43.0M | −$85.7M | −$83.0M | −$13.3M | |
| Diluted EPS | $0.01 | −$0.01 | $0.37 | −$0.75 | −$0.73 | −$0.12 | |
| Gross margin | 9.0% | 7.9% | 10.7% | 1.9% | 4.8% | 9.8% | |
| Operating margin | 2.7% | 2.0% | 0.0% | -3.8% | -4.4% | 2.7% |
Fiscal years (4-quarter sums)FY21 $8.91B · FY22 $9.38B · FY23 $6.83B · FY24 $6.54B · FY25 $6.78B
Revenue by product · Q2 FY26
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $177.4M · Total debt $3.41B · Total assets $7.44B · Shareholders' equity $1.71B
Dividends
Raised for 38 straight years. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 27, 2026 | Aug 27 | Sep 11 | $0.20 | |
| May 14, 2026 | May 14 | Jun 12 | $0.20 | |
| Mar 3, 2026 | Mar 3 | Mar 13 | $0.20 | |
| Nov 28, 2025 | Nov 28 | Dec 12 | $0.20 | |
| Aug 28, 2025 | Aug 28 | Sep 12 | $0.20 | |
| May 15, 2025 | May 15 | Jun 13 | $0.20 | |
| Mar 6, 2025 | Mar 6 | Mar 14 | $0.20 | |
| Nov 14, 2024 | Nov 14 | Dec 13 | $0.20 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 113.98M · Float 113.26M · 99.4% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Hotchkis & Wiley Capital Management LLC | 16.02M | 14.06% | 13F | Aug 14, 2026 |
| BlackRock, Inc. | 11.98M | 10.51% | 13F | Aug 7, 2026 |
| Dimensional Fund Advisors LP | 6.17M | 5.40% | 13G | Jul 14, 2026 |
| AQR Capital Management, LLC | 5.74M | 5.04% | 13G | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 5.45M | 4.78% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Feb 25, 2026 | Deon Carter | officer: VP & President CAPV | −6,500 | $23.73 |
| Feb 24, 2026 | Angela M. Castle | officer: VP & Chief Legal Officer | −2,379 | $24.25 |
| Feb 3, 2026 | Todd A. Slater | officer: VP & CFO | −92,250 | $22.48 |
| Feb 3, 2026 | R. Nichole Sumner | officer: VP & Controller | −4,750 | $22.49 |
| Nov 26, 2025 | Teresa M. Vermillion | officer: VP & Treasurer | −4,500 | $20.86 |
Peers
- Westlake
Chlor-alkali, vinyls, and epoxy overlap across core chemical markets
- Occidental Petroleum
Chlor-alkali and vinyls overlap in North American commodity chemicals
- Huntsman
Epoxy materials overlap; announced combination remains pending
- General Dynamics
Small-caliber military ammunition overlaps with Winchester programs
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Olin | $17.26 | +0.64% | $1.95B | — | 51.4 | 0.3 | −0.9% |
| Westlake | $75.71 | −0.07% | $9.70B | — | 19.9 | 0.9 | +10.8% |
| Occidental Petroleum | $59.23 | +0.23% | $58.78B | 9.1 | 13.2 | 2.3 | +27.7% |
| Huntsman | $9.55 | +0.79% | $1.66B | — | 325.5 | 0.3 | +14.1% |
| General Dynamics | $376.45 | −0.75% | $102.63B | 23.1 | 21.7 | 1.9 | +8.1% |
| Median | 16.1 | 20.8 | 1.4 | +12.4% |